Notify me when COLUMN GROUP III, LP files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| TNYA | Tenaya Therapeutics, Inc. | Common Stock, par value $0.0001 per share | 23% | $67,066,440 | 49,313,559 | 0% | The Column Group Opportunity III, LP | 15 Dec 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|